Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy

被引:2
|
作者
Hong, Sung Kyu [1 ,2 ]
Eastham, James A. [2 ,3 ]
Fine, Samson W. [4 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10065 USA
[3] Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
Prostate; Prostatic neoplasms; Active surveillance; Prostate biopsy; Gleason score;
D O I
10.12954/PI.13029
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate actual intraprostatic location of higher graded tumor foci undetected via standard transrectal ultrasoundguided prostate biopsy amongst patients who would be clinically considered appropriate candidates for active surveillance (AS) but underwent radical prostatectomy (RP). Methods: We reviewed entirely-submitted and whole-mounted RP specimens from 169 men who were deemed appropriate for AS clinically, but opted for RP and were found to have higher grade tumors. For each case, tumor nodules were circled and color-coded in a grade-specific manner and digitally scanned to created tumor maps. The locations of tumor foci with Gleason grade >= 4 were stratified by specific sites: anterior, anterolateral, lateral only (not clearly anterior or posterior), posterior, and posterolateral area. Results: Of 169 patients, 86% had clinical stage T1c and 14% T2a. RP Gleason score 7 in all but two men. Higher-grade tumor foci were localized to: anterior (n=66, 39%), anterolateral (n=4, 2%), lateral only (not clearly anterior or posterior) (n=5, 3%), posterior (n=52, 31%), and posterolateral (n=42, 25%) prostate, respectively. Conclusions: Among patients deemed clinically appropriate for AS, higher-grade tumor foci missed by standard prostate biopsies were localized to both the anterior and posterior prostate, without predominance of a particular area. These findings lend additional support to performing repeat standard prostate biopsy in potential candidates for AS and should be considered in efforts to optimize current biopsy strategies for the selection of AS patients.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [41] Pathological features after radical prostatectomy in potential candidates for active monitoring - Reply by authors
    不详
    JOURNAL OF UROLOGY, 2007, 178 (03): : 863 - 863
  • [42] DOES THE NUMBER OF GLEASON 6 POSITIVE CORES ON PROSTATE BIOPSY PREDICT ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE?
    Audenet, Francois
    Vertosick, Emily
    Fine, Samson
    Sanchez-Salas, Rafael
    Galiano, Marc
    Barret, Eric
    Cathelineau, Xavier
    Rozet, Francois
    Eastham, James
    Scardino, Peter
    Touijer, Karim
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1191 - E1191
  • [43] Comparison of Pathological Outcomes of Active Surveillance Candidates Who Underwent Radical Prostatectomy Using Contemporary Protocols at a High-volume Korean Center
    Lee, Dong Hoon
    Jung, Ha Bum
    Lee, Seung Hwan
    Rha, Koon Ho
    Choi, Young Deuk
    Hong, Sung Jun
    Yang, Seung Choul
    Chung, Byung Ha
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (11) : 1079 - 1085
  • [44] Oncological outcome in patients candidates to active surveillance undergoing radical prostatectomy. Influence from upgrading
    Veiga, Gomez F.
    Breijo, S.
    Pertega, S.
    Dacal, J.
    Ponce, J.
    Zarraonaindia, A.
    Casas, J.
    Busto, L.
    Barghouty, I
    Pita, S.
    Abal, V
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E1095 - U279
  • [45] Defining the risk of disease progression following radical prostatectomy in candidates for active surveillance using the PRIAS criteria
    El Hajj, A.
    Ploussard, G.
    Radulescu, C.
    Defourmestraux, A.
    Gillion, N.
    Vordos, D.
    Hoznek, A.
    Yiou, R.
    Allory, Y.
    De La Taille, A.
    Abbou, C. C.
    Salomon, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E1090 - U269
  • [46] PATHOLOGICAL OUTCOMES OF CANDIDATES FOR PRIAS AND JOHNS HOPKINS ACTIVE SURVEILLANCE PROTOCOLS TREATED WITH IMMEDIATE RADICAL PROSTATECTOMY
    Lacetera, Vito
    Galosi, Andrea
    Conti, Alessandro
    Cantoro, Daniele
    Mazzucchelli, Roberta
    Montironi, Rodolfo
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2011, 31 (05) : 1917 - 1918
  • [47] CORRELATION BETWEEN A GENOMICS TEST AND ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY AMONG ACTIVE SURVEILLANCE CANDIDATES
    Hurley, Patrick
    Auffenberg, Greg
    Qi, Ji
    Maurino, Chris
    Farida, Samantha
    Latifi, Ivi
    Moylan, Donald
    Johnson, Bincy
    Miller, David
    Wojno, Kirk
    JOURNAL OF UROLOGY, 2017, 197 (04): : E517 - E518
  • [48] PATHOLOGICAL ANALYSIS OF PATIENTS UNDERGOING RADICAL PROSTATECTOMY WHO WERE POTENTIAL CANDIDATES FOR FOCAL THERAPY
    Soares, Ricardo
    Laing, Robert
    Haagsma, Ben
    Patil, Krishna
    Eden, Christopher
    Langley, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1042 - E1042
  • [49] CANDIDATES FOR ACTIVE SURVEILLANCE WHO UNDERWENT ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY; PATHOLOGICAL SPECIMEN CHARACTERISTICS.
    Collette, E. R. P.
    Engel, R. P.
    Kliffen, M.
    van den Ouden, D.
    Klaver, O. S.
    BJU INTERNATIONAL, 2012, 110 : 74 - 75
  • [50] Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy
    Drouin, Sarah J.
    Comperat, Eva
    Cussenot, Olivier
    Bitker, Marc-Olivier
    Haertig, Alain
    Roupret, Morgan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 402 - 407